Clinical Trial Update: Investigation of the Pharmacokinetic Properties of Biphasic Insulin Aspart 50 in Healthy Chinese Subjects [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial investigates the pharmacokinetics of Biphasic Insulin Aspart 50 in healthy Chinese subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 50 (insulin aspart, biphasic 50/50)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED